BIOCERES CROP SOLUTIONS CORP. Income Tax Relating To Changes In Revaluation Surplus Of Other Comprehensive Income
BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Income Tax Relating To Changes In Revaluation Surplus Of Other Comprehensive Income of -$703.09 thousand for the 12-month period ending 2023-06-30, per its 20-F filed 2025-11-10.
Financial Statements › Expense Statement › Income Tax
ifrs-full:IncomeTaxRelatingToChangesInRevaluationSurplusOfOtherComprehensiveIncome · last filed 2025-11-10
- BIOCERES CROP SOLUTIONS CORP. income tax relating to changes in revaluation surplus of other comprehensive income for the quarter ending 2023-06-30 was -$703.09K.
- BIOCERES CROP SOLUTIONS CORP. income tax relating to changes in revaluation surplus of other comprehensive income for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. income tax relating to changes in revaluation surplus of other comprehensive income for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. income tax relating to changes in revaluation surplus of other comprehensive income for the quarter ending 2022-06-30 was -$5.07M.
| Period end | Income Tax Relating To Changes In Revaluation Surplus Of Other Comprehensive Income 3 month | Income Tax Relating To Changes In Revaluation Surplus Of Other Comprehensive Income 6 month | Income Tax Relating To Changes In Revaluation Surplus Of Other Comprehensive Income 6 month as first filed | Income Tax Relating To Changes In Revaluation Surplus Of Other Comprehensive Income 9 month | Income Tax Relating To Changes In Revaluation Surplus Of Other Comprehensive Income 12 month | Income Tax Relating To Changes In Revaluation Surplus Of Other Comprehensive Income 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-06-30 | -$703.09K derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | -$703.09K derived: sum of 2 quarters · filed 2025-11-10 | -$703.09K derived: sum of 3 quarters · filed 2025-11-10 | -$703.09K 20-F · filed 2025-11-10 | ||
| 2023-03-31 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2023-05-24 | $0.00 derived: sum of 2 quarters · filed 2023-05-24 | $0.00 6-K · filed 2023-05-24 | |||
| 2022-12-31 | $0.00 6-K · filed 2023-02-28 | $0.00 6-K · filed 2023-02-28 | ||||
| 2022-06-30 | -$5.07M derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | -$4.16M derived: sum of 2 quarters · filed 2024-10-30 | -$3.49M derived: sum of 3 quarters · filed 2024-10-30 | -$2.84M 20-F · filed 2024-10-30 | ||
| 2022-03-31 | $902.14K 6-K · filed 2023-05-24 | $1.57M derived: sum of 2 quarters · filed 2023-05-24 | $2.23M 6-K · filed 2023-05-24 | |||
| 2021-12-31 | $672.21K 6-K · filed 2023-02-28 | $1.33M 6-K · filed 2023-02-28 | ||||
| 2021-06-30 | $1.39M 20-F · filed 2023-11-14 | -$1.39M 20-F · filed 2021-10-29 | ||||
| 2020-12-31 | $863.00 6-K · filed 2022-02-25 | $35.20K 6-K · filed 2022-02-25 | -$48.77K 6-K · filed 2021-02-26 | |||
| 2020-06-30 | $1.13M 20-F · filed 2022-10-28 | |||||
| 2019-12-31 | $795.62K 6-K · filed 2021-02-26 | |||||
| 2019-06-30 | $480.38K 20-F · filed 2021-10-29 | -$480.38K 20-F · filed 2019-10-24 | ||||
| 2018-12-31 | $53.82K 6-K/A · filed 2020-03-17 | |||||
| 2018-06-30 | $4.51M 20-F · filed 2020-10-21 | |||||
| 2017-06-30 | $1.01M 20-F · filed 2019-10-24 | |||||
| 2016-12-31 | $0.00 20-F · filed 2019-10-24 |